Drug Shortage Report for NEOSTIGMINE OMEGA

Last updated on 2020-04-01 History
Report ID 109785
Drug Identification Number 02230593
Brand name NEOSTIGMINE OMEGA
Common or Proper name Neostigmine Methylsulfate Injection USP
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) NEOSTIGMINE METHYLSULFATE
Strength(s) 0.5MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 10mL vial /fiole
ATC code N07AA
ATC description PARASYMPATHOMIMETICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-17
Estimated end date Unknown
Actual end date 2020-03-31
Shortage status Resolved
Updated date 2020-04-01
Company comments Preventive Allocation (COVID-19)
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-04-01 English Compare
v4 2020-03-31 French Compare
v3 2020-03-31 English Compare
v2 2020-03-30 French Compare
v1 2020-03-30 English Compare

Showing 1 to 5 of 5